4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, a Nicotine-derived Carcinogenic Nitrosaminoketone (NNK): Three-dimensional Structure

被引：0
|
作者：
Amy K. Katz
H. L. Carrell
Carol E. Afshar
Jenny P. Glusker
Dhimant Desai
Shantu Amin
机构：
[1] The Institute for Cancer Research,Fox Chase Cancer Center
[2] American Health Foundation,undefined
来源：
Structural Chemistry | 1999年 / 10卷
关键词：
Nicotine-derived nitrosaminoketone; nitrosamine; crystal structure; molecular dimensions;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The three-dimensional structure of the carcinogenic nicotine-derived nitrosaminoketone, 4-(methyl-nitrosamino)-l-(3-pyridyl)-l-butanone, has been determined by X-ray crystallographic techniques. The molecule is essentially planar except for the methylnitrosamine group which is oriented at a dihedral angle of 68.7° to the pyridine ring. Molecules pack by way of —H⋯O interactions that involve the —NNO group.
引用
收藏
页码：439 / 443
页数：4
相关论文
共 50 条
  • [41] BILIARY-EXCRETION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE IN THE RAT
    SCHULZE, J
    RICHTER, E
    BINDER, U
    ZWICKENPFLUG, W
    CARCINOGENESIS, 1992, 13 (11) : 1961 - 1965
  • [42] METABOLISM OF A GLUCURONIDE CONJUGATE OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE IN RATS
    ATAWODI, SEO
    MICHELSEN, K
    RICHTER, E
    ARCHIVES OF TOXICOLOGY, 1994, 69 (01) : 14 - 17
  • [43] EFFECTS OF DEUTERIUM SUBSTITUTION ON THE TUMORIGENICITY OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE AND 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL IN A/J MICE
    HECHT, SS
    JORDAN, KG
    CHOI, CI
    TRUSHIN, N
    CARCINOGENESIS, 1990, 11 (06) : 1017 - 1020
  • [44] GLUCURONIDATION OF 4-((HYDROXYMETHYL)NITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE, A METABOLICALLY ACTIVATED FORM OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE, BY PHENOBARBITAL-TREATED RATS
    MURPHY, SE
    SPINA, DA
    NUNES, MG
    PULLO, DA
    CHEMICAL RESEARCH IN TOXICOLOGY, 1995, 8 (05) : 772 - 779
  • [45] Physico-chemical properties of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) diazonium ion: a theoretical investigation
    Deligkaris, Christos
    Millam, Evan
    Wade, Edmir O.
    Grayer, Maverick L.
    Wahl, David M.
    RSC ADVANCES, 2021, 11 (43) : 26750 - 26762
  • [46] Disposition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in bile duct-cannulated rats: Stereoselective metabolism and tissue distribution
    Wu, Z
    Upadhyaya, P
    Carmella, SG
    Hecht, SS
    Zimmerman, CL
    CARCINOGENESIS, 2002, 23 (01) : 171 - 179
  • [47] Comparative metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in lung tissue slices from rodents and man
    Engl, J
    Richter, E
    Tricker, AR
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R434 - R434
  • [48] Cytokine production by alveolar macrophages is down regulated by the α-methylhydroxylation pathway of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)
    Proulx, LI
    Castonguay, A
    Bissonnette, EY
    CARCINOGENESIS, 2004, 25 (06) : 997 - 1003
  • [49] IMMUNOCYTOCHEMICAL IDENTIFICATION OF DNA METHYLATION BY 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE (NNK) IN NASAL TISSUES OF RAT AND HAMSTER
    VANBENTHEM, J
    WILMER, JWGM
    LEEMAN, WR
    WINTERWERP, HHK
    DENENGELSE, L
    SCHERER, E
    NASAL CARCINOGENESIS IN RODENTS : RELEVANCE TO HUMAN HEALTH RISK, 1989, : 231 - 231
  • [50] IPOMEANOL ANALOGS AS CHEMOPREVENTIVE AGENTS - EFFECT ON THE IN-VITRO METABOLISM OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE (NNK)
    DESAI, D
    NUNES, M
    CHANG, L
    LIN, JM
    JIAO, D
    AMIN, S
    CANCER LETTERS, 1995, 97 (02) : 155 - 162
12345